Standout Papers
- Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis (2004)
- Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1) (2015)
- Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor (2014)
Immediate Impact
4 by Nobel laureates 20 from Science/Nature 68 standout
Citing Papers
Bispecific T cell engager therapy for refractory rheumatoid arthritis
2024 Standout
CAR T-cell therapy in autoimmune diseases
2023 Standout
Works of Randall M. Stevens being referenced
Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis
2004 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Randall M. Stevens | 2472 | 296 | 2044 | 868 | 43 | 4.8k | |
| C. Birbara | 3705 | 517 | 1875 | 1738 | 42 | 5.4k | |
| Thasia Woodworth | 4066 | 368 | 2293 | 1481 | 84 | 7.3k | |
| P. Charles | 2972 | 142 | 1732 | 740 | 93 | 6.0k | |
| P. A. Bacon | 2063 | 66 | 953 | 453 | 63 | 3.6k | |
| David E. Trentham | 2953 | 278 | 1808 | 621 | 88 | 6.3k | |
| Jacek Szechiński | 2888 | 87 | 1443 | 1125 | 58 | 4.9k | |
| Arthur L. Weaver | 3423 | 1006 | 1045 | 1496 | 38 | 5.5k | |
| John J. Cush | 2469 | 151 | 1561 | 1130 | 58 | 4.2k | |
| E. Martín‐Mola | 4085 | 561 | 1513 | 1460 | 110 | 5.9k | |
| Jon T. Giles | 3517 | 139 | 1422 | 896 | 151 | 6.4k |
All Works
Loading papers...